Skip to content

Advertisement

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case

  • Martin G. Belinsky1Email author,
  • Lori Rink1,
  • Kathy Q. Cai2,
  • Stephen J. Capuzzi1, 3,
  • Yen Hoang4, 5,
  • Jeremy Chien5,
  • Andrew K. Godwin6 and
  • Margaret von Mehren1
BMC Cancer201515:887

https://doi.org/10.1186/s12885-015-1872-y

Received: 22 July 2015

Accepted: 30 October 2015

Published: 10 November 2015

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
22 Jul 2015 Submitted Original manuscript
28 Aug 2015 Reviewed Reviewer Report - Shiva Keshava
28 Aug 2015 Reviewed Reviewer Report - Ghanshyam Upadhyay
9 Sep 2015 Author responded Author comments - Martin Belinsky
Resubmission - Version 2
9 Sep 2015 Submitted Manuscript version 2
16 Oct 2015 Author responded Author comments - Martin Belinsky
Resubmission - Version 3
16 Oct 2015 Submitted Manuscript version 3
Publishing
30 Oct 2015 Editorially accepted
10 Nov 2015 Article published 10.1186/s12885-015-1872-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, USA
(2)
Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, USA
(3)
Division of Chemical Biology and Medicinal Chemistry, University of North Carolina, Chapel Hill, USA
(4)
Department of Bioinformatics and Biosystems Technology, University of Applied Sciences Wildau, Wildau, Germany
(5)
Department of Cancer Biology, University of Kansas Medical Center, Kansas City, USA
(6)
Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, USA

Advertisement